Expand EVAX Menu
EVAX MENU

EVAX Latest Press Releases

-- December 6, 2025 --

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting Globe Newswire 2:00 PM

-- November 20, 2025 --

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1 Globe Newswire 8:00 AM

-- November 12, 2025 --

Evaxion announce 2026 financial calendar Globe Newswire 8:00 AM

-- November 7, 2025 --

Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 Globe Newswire 5:10 PM

-- November 6, 2025 --

Evaxion announces business update and third quarter 2025 financial results Globe Newswire 7:30 AM

-- November 3, 2025 --

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate Globe Newswire 9:00 AM

-- October 31, 2025 --

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 Globe Newswire 9:05 AM
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 Globe Newswire 8:00 AM

-- October 30, 2025 --

Evaxion raises $7.2 million, extending cash runway to second half of 2027 Globe Newswire 8:00 AM

-- October 27, 2025 --

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer Globe Newswire 8:00 AM

-- October 17, 2025 --

Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01 Globe Newswire 8:15 AM

-- October 13, 2025 --

Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 Globe Newswire 8:00 AM

-- October 8, 2025 --

Evaxion expands AI-Immunology platform with automated vaccine design module Globe Newswire 8:12 AM

-- October 3, 2025 --

Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting Globe Newswire 9:00 AM

-- September 25, 2025 --

Evaxion out-licenses vaccine candidate EVX-B3 to MSD Globe Newswire 7:00 AM

-- August 27, 2025 --

Evaxion to present at several conferences during the second half of 2025 Globe Newswire 8:00 AM

-- August 14, 2025 --

Evaxion announces business update and second quarter 2025 financial results Globe Newswire 7:30 AM

-- August 11, 2025 --

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025 Globe Newswire 8:00 AM

-- July 25, 2025 --

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 Globe Newswire 9:00 AM

-- July 11, 2025 --

Evaxion finalizes agreement with EIB to convert debt into equity Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes